Search the Newsreel

Brand Concepts Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Stifel cuts OptimizeRx stock price target on revenue headwinds

Stifel has lowered its price target for OptimizeRx (NASDAQ: OPRX) to $12 from $14, while maintaining a Buy rating, due to significant revenue headwinds. The company reported a 30% year-over-year revenue decline in Q2 2026, though adjusted earnings per share exceeded expectations. OptimizeRx reiterated …

AirSculpt Technologies, Inc. Just Missed Earnings; Here's What Analysts Are Forecasting Now

AirSculpt Technologies (NASDAQ: AIRS) shares dropped 34% after missing second-quarter revenue predictions and reporting a statutory loss. Analysts have since increased loss per share expectations for 2026 and significantly cut the average price target, signaling concerns about growing losses and slower revenue growth compared …

Massachusetts Biotech's Flagship Gene Therapy Posts Fifth Straight Quarterly Decline as Muscular Dystrophy Data Loom

Sarepta Therapeutics (SRPT) saw its flagship gene therapy, ELEVIDYS, experience a fifth consecutive quarterly revenue decline, with analysts from H.C. Wainwright & Co. reiterating a Sell rating and a $5.00 price target. Despite this, the market reaction was muted, suggesting investors are assigning significant …

Credit Acceptance names former Amazon AI executive as CTO

Credit Acceptance Corporation announced the appointment of Jeetu Mirchandani, a former Amazon AI executive, as its new Chief Technology Officer, effective August 27, 2026. Mirchandani brings over two decades of technology leadership from Amazon, where he specialized in applied AI, supply chain technology, personalization, …

Credit Acceptance Announces New Chief Technology Officer to Advance Digital-First, AI-Enabled Business Evolution

Credit Acceptance Corporation (CACC) has appointed Jeetu Mirchandani as its new Chief Technology Officer, effective August 27, 2026. Mirchandani, with over two decades of leadership experience at Amazon, will spearhead the company's engineering and technology strategy, focusing on accelerating its digital-first, AI-enabled evolution. This …

PRCT DEADLINE: ROSEN, A LEADING LAW FIRM Encourages PROCEPT

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who suffered losses exceeding $100K to secure counsel before the September 22, 2026, lead plaintiff deadline. The firm reminds purchasers of PRCT common stock between February 28, 2024, and February 25, …

Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against AdaptHealth Corp. (AHCO) after the company reported significantly lower-than-expected Q2 2026 revenue and adjusted EBITDA, along with a substantial reduction in full-year guidance. The firm encourages investors who purchased AdaptHealth securities to connect with …

Amazon’s Applied AI Head Will Join Credit Acceptance Aug. 27

Credit Acceptance (Nasdaq: CACC) has appointed Jeetu Mirchandani, a veteran technology and AI executive from Amazon, as its new Chief Technology Officer, effective August 27, 2026. Mirchandani will lead the company's Engineering organization and technology strategy to accelerate its digital-first, AI-enabled evolution. His extensive …

Dickson Concepts says U.K. Harvey Nichols sale will not affect Hong Kong operations

Indaptus Therapeutics, Inc. 2Q 2026: Net loss $(1.79M), EPS $(0.02) — 10-Q Summary

Indaptus Therapeutics, Inc. reported a significant improvement in its financial results for the second quarter of 2026, with a net loss of $(1.79M) and EPS of $(0.02), primarily due to reduced R&D and G&A spending following the wind-down of its Decoy20 Phase 1 study. …

Indaptus Therapeutics (INDP) slashes R&D costs and bolsters cash after $12M raise

Indaptus Therapeutics (INDP) significantly reduced its operating expenses and net loss in Q2 2026, bolstering its cash reserves with a $12 million private placement. The company reported an 83% drop in R&D costs and a narrowed net loss of $1.8 million, while it evaluates …

Indaptus Therapeutics (Nasdaq: INDP) cuts losses and raises $12M in Q2

Indaptus Therapeutics (INDP) significantly reduced its net loss in Q2 2026 to $1.8 million from $5.2 million in the previous year, primarily due to an 83% cut in R&D and a 37% decline in G&A expenses as it halted its Decoy20 clinical program and …

PTC Therapeutics to Acquire ST-920 Fabry Gene Therapy

PTC Therapeutics (PTCT) is acquiring ST-920, a BLA-stage Fabry gene therapy, from Sangamo Therapeutics for $111 million upfront and up to $100 million in milestones. This acquisition aims to expand PTC's rare disease portfolio and facilitate accelerated FDA approval by late 2026, with a …

Dividend Investors: Don't Be Too Quick To Buy Tiptree Inc. (NASDAQ:TIPT) For Its Upcoming Dividend

Tiptree Inc. (NASDAQ:TIPT) is approaching its ex-dividend date on August 17th, with a dividend payment of US$0.06 per share, resulting in a trailing yield of 1.3%. However, the company reported a loss last year and has seen declining earnings, raising concerns about the sustainability …

Laba Bersih Bank Mandiri Tumbuh 24 Persen Hingga Juli 2026

Wedge Capital Management L L P NC Has $12.10 Million Position in Aptiv PLC $APTV

Wedge Capital Management L L P NC significantly increased its stake in Aptiv PLC (NYSE:APTV) by 32.4% in the second quarter, bringing its total holdings to 197,161 shares valued at $12.10 million. Other institutional investors also adjusted their positions in Aptiv, while an insider …

APT Electronics Sets Board Meeting to Review 2026 Interim Results and Dividend

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT falsely claimed consistent handpiece unit sales …

Understanding the Setup: (TIPT) and Scalable Risk

This article provides an analysis of Tiptree Inc. (NASDAQ: TIPT), highlighting its neutral readings in shorter horizons which could signal an easing of a long-term weak bias. It identifies an exceptional 42.0:1 risk-reward short setup targeting an 11.3% downside with a 0.3% risk. The …

Wasatch Advisors LP Has $8.90 Million Stock Holdings in Optex Systems Holdings Inc. $OPXS

Wasatch Advisors LP significantly increased its stake in Optex Systems Holdings Inc. by 59.4% in the second quarter, now owning 634,671 shares valued at $8.90 million, representing 9.12% of the company. Other institutional investors also raised their positions, though overall institutional ownership remains at …

Applied Optoelectronics (AAOI) Reported Q2 Results And New Guidance, Is The Valuation Too Rich?

Brand Concepts Q1 Results: Net loss widens 280% QoQ to ₹290 lakh

Arts Optical Sets Board Meeting to Approve 2026 Interim Results and Dividend

576,266 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Wasatch Advisors LP

Wasatch Advisors LP has acquired 576,266 shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) worth approximately $12.4 million, bringing institutional ownership in the company to 99.17%. Despite a reported wider-than-expected quarterly loss, Adaptive Biotechnologies saw a 21.5% year-over-year revenue increase. The stock is trading near its …

MetaOptics Deploys Metalens Direct Laser Writer at Stanford Nano Facility to Drive U.S. Expansion

Long Weekend 17 Agustus, Okupansi Eastparc Hotel (EAST) Hampir 100%

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

OptimizeRx has announced significant finance leadership appointments, effective January 1, 2027, as part of its succession planning. Andy D’Silva will take over as Chief Financial Officer, succeeding Ed Stelmakh, who will transition to a Strategic Advisor role. Heather Favazza has been appointed Chief Accounting …

Easterly Government Properties, Inc. $DEA Shares Purchased by Renaissance Technologies LLC

Renaissance Technologies LLC significantly increased its holdings in Easterly Government Properties (NYSE:DEA) by 198.6% in the first quarter, now owning 73,466 shares valued at $1.57 million. Other institutional investors also adjusted their stakes, with overall institutional ownership at 86.51%. The company reported a 9.8% …

Jelang Lapkeu Semester I, Cek Target dan Rekomendasi Saham ANTM

Corcept chief development officer sells $418,561 of stock

Corcept Therapeutics Inc.'s Chief Development Officer, William Guyer, sold 3,700 shares of the company's stock for $418,561, while simultaneously acquiring the same number of shares through stock options for $80,105. This transaction comes as Corcept's stock has seen significant gains, trading near its 52-week …

Adaptive Biotechnologies (ADPT) CCO Bobulsky sells 3,000 shares under plan

Adaptive Biotechnologies' Chief Commercial Officer, MRD, Susan Bobulsky, sold 3,000 shares of common stock at $25.00 per share on August 10, 2026. This transaction was conducted under a Rule 10b5-1 trading plan established on December 16, 2025. Following the sale, Bobulsky directly holds 396,989 …

SRPT|Sarepta Therapeutics Inc|Price:17.890|Chg%:-0.530

Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales

Adaptive Biotechnologies (ADPT) stock appears fairly valued based on its discounted cash flow model, which places its intrinsic value close to its current share price. However, the stock looks expensive when evaluated using market multiples, particularly its P/S ratio, which is significantly higher than …

OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...

OptimizeRx Corp (OPRX) reported a 30% year-over-year revenue decrease in Q2 2026, reaching $20.5 million, with adjusted EBITDA falling to $4.1 million. Despite these revenue headwinds, the company exceeded consensus expectations, driven by strong growth in AI-enabled software and product innovations. OptimizeRx reaffirmed its …

Aptiv PLC (APTV) Stock forecasts

Argus analyst William V. Selesky views recent weakness in Aptiv PLC (APTV) stock as a long-term buying opportunity. The report notes Aptiv manufactures vehicle components and has reorganized its segments, renaming Advanced Safety and User Experience to Intelligent Systems following the spin-off of its …